Duration of diabetes and cardiorenal efficacy of liraglutide and semaglutide: A post hoc analysis of the LEADER and SUSTAIN 6 clinical trials-Reference-Cited by-同舟云学术

Duration of diabetes and cardiorenal efficacy of liraglutide and semaglutide: A post hoc analysis of the LEADER and SUSTAIN 6 clinical trials

Published:2019-04-02 Issue:7 Volume:21 Page:1745-1751
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Verma Subodh¹^ORCID,Bain Stephen C.²^ORCID,Monk Fries Tea³,Mazer C. David¹,Nauck Michael A.⁴^ORCID,Pratley Richard E.⁵^ORCID,Rasmussen Søren³,Saevereid Hans A.³,Zinman Bernard⁶^ORCID,Buse John B.⁷

Affiliation:

1. Department of Anesthesia, Division of Cardiac Surgery, St. Michael's Hospital and University of Toronto Toronto Ontario Canada

2. Institute of Life Science, Swansea University Medical School Swansea UK

3. Novo Nordisk A/S Søborg Denmark

4. Diabetes Center Bochum‐Hattingen, St Josef Hospital (Ruhr‐Universität Bochum) Bochum Germany

5. Florida Hospital Translational Research Institute for Metabolism and Diabetes Orlando Florida

6. Lunenfeld–Tanenbaum Research Institute, Mt. Sinai HospitalUniversity of Toronto Toronto Ontario Canada

7. Department of MedicineUniversity of North Carolina School of Medicine Chapel Hill North Carolina

Funder

Novo Nordisk

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.13698

Reference13 articles.

1. The Significant Effect of Diabetes Duration on Coronary Heart Disease Mortality

2. Effect of diabetes duration and glycaemic control on 14-year cause-specific mortality in Mexican adults: a blood-based prospective cohort study

3. Impact of diabetes duration on the extent and severity of coronary atheroma burden and long-term clinical outcome in asymptomatic type 2 diabetic patients: evaluation by Coronary CT angiography

4. Impact of Diabetes on Cardiovascular Disease Risk and All-Cause Mortality in Older Men

5. Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From diabetes to diverse domains: the multifaceted roles of GLP-1 receptor agonists;Molecular Biology Reports;2024-07-23

2. Semaglutide and obesity: beyond the nutritional and lifestyle intervention?;Minerva Endocrinology;2024-07

3. GLP-1 receptor agonists and atherosclerosis protection: the vascular endothelium takes center stage;American Journal of Physiology-Heart and Circulatory Physiology;2024-05-01

4. Differential ischemic stroke risk linked to novel subtypes of type 2 diabetes: insights from a Mendelian randomization analysis;Endocrine;2024-04-30

5. Semaglutide in type 2 diabetes management: review of current evidence from concept to date;FOCUS. Endocrinology;2023-12-27